Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?

Published:2019-05-08 Issue:1 Volume:39 Page:25
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Wang Jin¹,Tang Hailin¹,Li Xing¹,Song Cailu¹,Xiong Zhenchong¹,Wang Xi¹,Xie Xiaoming¹,Tang Jun¹

Affiliation:

1. Department of Breast Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine; Sun Yat-sen University Cancer Center; No. 651 Dongfeng East Road, Yuexiu District Guangzhou 510060 Guangdong P.R. China

Funder

National Natural Science Foundation of China

Young Investigator Award

Medical scientist training program

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s40880-019-0371-y.pdf

Reference36 articles.

1. The influence of stage at diagnosis and molecular subtype on breast cancer patient survival: a hospital-based multi-center study;Zuo;Chin J Cancer,2017

2. Research needs in breast cancer;Cardoso;Ann Oncol.,2017

3. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial;Krag;Lancet Oncol.,2010

4. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial;Galimberti;Lancet Oncol.,2013

5. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial;Giuliano;Ann Surg.,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival After Sentinel Lymph Node Biopsy Compared with Axillary Lymph Node Dissection for Female Patients with T3-4c Breast Cancer;The Oncologist;2023-03-17

2. Long-term outcome and axillary recurrence in elderly women (≥70 years) with breast cancer: 10-years follow-up from a matched cohort study;European Journal of Surgical Oncology;2021-07

3. Meme Kanserinde Sağkalım Durumunu Etkileyen Faktörlerin İncelenmesi: Eğilim Skoru Analizi;Kocaeli Üniversitesi Sağlık Bilimleri Dergisi;2021-01-05

4. Predicting Survival Benefit of Sparing Sentinel Lymph Node Biopsy in Low-Risk Elderly Patients With Early Breast Cancer: A Population-Based Analysis;Frontiers in Oncology;2020-09-11

5. Challenge for Diagnostic Assessment of Deep Learning Algorithm for Metastases Classification in Sentinel Lymph Nodes on Frozen Tissue Section Digital Slides in Women with Breast Cancer;Cancer Research and Treatment;2020-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3